<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://tuvaluhealthdigest.com/article/904086918-beacon-biosignals-upsizes-series-b-financing-to-over-97-million</loc>
      <news:news>
        <news:publication>
          <news:name>Tuvalu Health Digest</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T10:30:00+00:00</news:publication_date>
        <news:title>Beacon Biosignals Upsizes Series B Financing to Over $97 Million</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0485bb01-d362-473e-8fae-a6cab3b804aa/small/beacon-logo-inline-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://tuvaluhealthdigest.com/article/904084259-profusa-expands-into-multi-billion-dollar-precision-diagnostics-market-with-30m-letter-of-intent-for-a-panomics-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Tuvalu Health Digest</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T10:00:00+00:00</news:publication_date>
        <news:title>Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a8137a61-b858-48da-9e47-1f1bf8f6ddba/small/profusa-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://tuvaluhealthdigest.com/article/903833852-medvi-quad-claims-evaluated-real-online-doctor-approval-ed-medication-for-men-s-sexual-performance</loc>
      <news:news>
        <news:publication>
          <news:name>Tuvalu Health Digest</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-04T20:05:45+00:00</news:publication_date>
        <news:title>MEDVi QUAD Claims Evaluated: Real Online Doctor-Approval ED Medication for Men&#39;s Sexual Performance</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/MEDVi-QUAD.jpg</image:loc>
        </image:image>
    </url>
</urlset>
